Rifabutin

Product NDC
60687-198
11-digit product format
606870198
Labeler code
60687
Product ID
60687-198_9f7b9f44-e86d-1574-e053-2a95a90a8223
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rifabutin
Dosage form
CAPSULE
Route
ORAL
Labeler
American Health Packaging
Application
ANDA090033
Marketing category
ANDA
Marketing start
2016-06-08
Marketing end
2021-01-31
Substance
RIFABUTIN
Active strength
150 mg/1
Pharmacologic classes
Rifamycin Antimycobacterial [EPC],Rifamycins [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct60687-198DDiscontinued by firm2026-07-31
excluded packagepackage60687-19860687-198-25DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A090033-001RIFABUTINRIFABUTIN150MGCAPSULE / ORAL2014-02-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A090033-001RIFABUTIN150MGCAPSULE / ORAL2014-02-24a50c72e98297…